R
Robert Resnik
Researcher at University of California, San Diego
Publications - 71
Citations - 5748
Robert Resnik is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Pregnancy & Placenta accreta. The author has an hindex of 29, co-authored 71 publications receiving 5556 citations. Previous affiliations of Robert Resnik include Naval Medical Center San Diego.
Papers
More filters
Journal ArticleDOI
Intrauterine growth restriction.
TL;DR: Careful monitoring of fetal growth and well-being, combined with appropriate timing and mode of delivery, can best ensure a favorable outcome.
Journal ArticleDOI
Maternal-Fetal Medicine: Principles and Practice
Robert K. Creasy,Robert Resnik +1 more
TL;DR: Contrary to their predecessors, Creasy and Resnik have masterfully encompassed the boundaries of the subspecialty in their textbook, Maternal-Fetal Medicine: Principles and Practice .
Book
Maternal-Fetal Medicine
Robert K. Creasy,Robert Resnik +1 more
TL;DR: The Prenatal Diagnosis of Structural Heart Disease and Doppler Ultrasound Assessment of Blood Flow, and the Endocrinology of Pregnancy: Clinical Characteristics and Management.
Journal ArticleDOI
Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta
Carri R. Warshak,Ramez N. Eskander,Andrew D. Hull,Angela L. Scioscia,Robert F. Mattrey,Kurt Benirschke,Robert Resnik +6 more
TL;DR: A two-stage protocol for evaluating women at high risk for placenta accreta, which uses ultrasonography first, and then MRI for cases with inconclusive ultrasound features, will optimize diagnostic accuracy.
Journal ArticleDOI
Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta.
Carri R. Warshak,Gladys A. Ramos,Ramez N. Eskander,Kurt Benirschke,Cheryl C. Saenz,Thomas F. Kelly,Thomas R. Moore,Robert Resnik +7 more
TL;DR: Predelivery diagnosis of placenta accreta is associated with decreased maternal hemorrhagic morbidity and Planned delivery at 34–35 weeks of gestation in this cohort did not significantly increase neonatal morbidity.